Pharmanutra
PHN.MIPharmanutra is a prominent Italian player in the nutraceutical and medical device sector, leveraging scientific research to create proprietary products for specific therapeutic areas. The company has achieved significant commercial success with its flagship brands and maintains a public listing, providing it with capital market access. Its core mission is to develop effective, evidence-based solutions for chronic conditions, with a strategic focus on both organic growth and potential market expansion.
PHN.MI · Stock Price
Historical price data
AI Company Overview
Pharmanutra is a prominent Italian player in the nutraceutical and medical device sector, leveraging scientific research to create proprietary products for specific therapeutic areas. The company has achieved significant commercial success with its flagship brands and maintains a public listing, providing it with capital market access. Its core mission is to develop effective, evidence-based solutions for chronic conditions, with a strategic focus on both organic growth and potential market expansion.
Technology Platform
Proprietary formulation and delivery technologies, including the Sucrosomial® platform for enhanced mineral absorption, focused on creating scientifically-validated nutraceutical and medical device products.
Pipeline
2| Drug | Indication | Stage | Watch |
|---|---|---|---|
| Treatment with oral sucrosomial iron + Treatment with intrav... | Anemia | Approved | |
| Ferric Maltol (Feraccru®) | Anemia | Approved |
Opportunities
Risk Factors
Competitive Landscape
Pharmanutra competes with large pharma OTC divisions (Bayer, Pfizer) and other Italian nutraceutical specialists (e.g., Abiogen). Its main competitive advantage is its strong scientific and medical positioning, relying on clinical data and physician recommendations rather than mass-market advertising, which creates higher barriers to entry and fosters brand loyalty in the pharmacy channel.